Aerometrex provided FY22 financial guidance update

Aerometrex Limited (ASX: AMX) provided an update on the expected financial results for the year ended 30 June 2022. The company anticipates its FY22 revenue to be in the range of AU$21 million to AU$23 million. The  EBITDA is expected to range in between AU$4.5 million to AU$5.5 million, which includes the gain on the sale of its corporate head office in January 2022 worth AU$2.8 million and the value of employee share options granted in FY20.

In addition, it also anticipates its annual recurring revenue for its subscription-based, MetroMap, to be in the range of AU$6.5 million to AU$7.0 million, up from AU$4.8 million in June 2021.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au